尼曼-皮克病的遗传基础,肺部参与和治疗选择:综合性审查
Claudio Tirelli1, Ornella Rondinone2, Marta Italia1
1Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Biomolecules
|February 24, 2024
概括
尼曼-皮克病 (NPD) 涉及遗传缺陷,导致溶酶体储存问题. 本综述详细介绍了肺部参与,诊断和治疗方法,如用于酸髓酶缺乏症 (ASMD) 的酶替代和用于NPD类型C的miglustat等.
科学领域:
- 遗传学和罕见疾病.
- 溶酶体储存障碍 溶酶体储存障碍
- 肺部病理学 肺部病理学
背景情况:
- 尼曼-皮克病 (NPD) 包含罕见的自体递归性溶酶体储存障碍.
- 类型A和B (酸髓酶缺乏症,ASMD) 源于SMPD1突变.
- 类型C涉及影响胆固醇贩运的NPC1/NPC2突变.
研究的目的:
- 审查尼曼-皮克病的遗传基础.
- 专注于肺部表现,诊断和当前/未来的治疗方法.
- 为提供NPD的最新概述,特别是肺部参与.
主要方法:
- 对NPD的遗传基础,临床特征和治疗选择的文献综述.
- 专注于诊断方式,如HRCT和肺部疾病的支气管镜检查.
- 对ASMD和NPD类型C的批准和实验性治疗方法的分析.
主要成果:
- 肺部参与是NPD中常见的,特别是B型,呈现为间歇性肺部疾病和感染.
- 高分辨率CT和支气管镜是肺部表现的关键诊断工具.
- 有限但有进步的治疗选择,包括酶替代 (ASMD的Olipudase α) 和基质减少 (NPD C的miglustat).
结论:
- 尼曼 - 皮克病带来了重大挑战,特别是在肺部健康方面.
- 早期诊断和向治疗对于管理NPD至关重要.
- 对新型治疗策略的持续研究为改善患者治疗结果提供了希望.
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
COPD: Pathogenesis and Clinical Features
273
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
273
Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90


